Enzyme | Electrode | Combination with CNTs | Forms of CNT | Linear range (mM) | LOD (μM) | Long-term stability | Real sample analysis | Refs. |
---|---|---|---|---|---|---|---|---|
GOx | GOx/VACNTs/PANI | Chemical vapor deposition | VACNTs | 0.002–0.426 | 1.1 | 45 days | Human serum | [69] |
GOx | acid-CNTs-2.5/PPy/FTO | Layer-by-layer modification | acid-CNTs | 0.01–0.7 | – | 14 days | Artificial saliva | [72] |
GOx | GOx/P(SNS-An-CO-EDOT)/CNTs | Polymerization | MWCNTs | 0.01–5.0 | 1.9 | 40 days 10% loss | Juice | [75] |
GOx | GOx/HRP/MWCNTs/Au foam | Electrodeposition | MWCNTs | 0.05–1.1 | 25 | 45 days | Human serum | [78] |
GOx | nGOx/N-CNTs-Chi/GCE | Situ polymerization | N-CNTs | 0.01–1.74 | 6.92 | 1 h 92% remained at 65 °C | – | [79] |
GOx | GOx@PAVE-CNTs | Non-covalent bonding | MWCNTs | 0.0001–5 | 0.36 | 35 days 92.4% remained | Human serum, Human urine | [80] |
GOx | PTFE/GOx/AuNPs/PANI/MWCNTs/GCE | Layer-by-layer assembly | MWCNTs | 0.0625–1.19 | 0.19 | 30 days at least 89.5% remained at 4 °C | Human serum | [83] |
GOx | GOx/AuNP/PANI/rGO/NH2-MWCNTs/SPCE | Single-step pyrolysis | MWCNTs | 1–10 | 64 | 30 days 96% remained at − 20 °C | Human serum | [84] |
GDH | GDH/amino-CNTs/graphene/thionine/AuNPs | Cyclic voltammetry treatment | NH2-CNTs | 0.5–6.9 | 50 | 3 weeks | – | [85] |
GDH | GDH/MG − Tb@mesoMOFs-CNTs/GCE | Hydrothermal process | f-CNTs (hydroxyl group and carboxyl group) | 0.025–17 | 8 | 10 days 98.2% remained | Human serum | [89] |
GOx | GOx/Au/MOFs (Fe, Mn)/CNTs | Hydrothermal process | acid-CNTs | 1.05–1.3 μM | 0.002 | – | Human serum | [90] |
GOx | PPG@Ru@UiO-66-NH2/GOx | Electrodeposition | Not mentioned | 1–10 | 5 | 7 days 95.2% remained | – | [91] |